Inge van Loo
Impact in
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus
- Clostridium difficile and Clostridium perfringens research
Papers in ⓘ
-
- Bacterial Identification and Susceptibility Testing 3
-
- Antimicrobial Resistance in Staphylococcus 3
- Parvovirus B19 Infection Studies 1
- Clostridium difficile and Clostridium perfringens research 1
- Co-authors
- Xander W. Huijsdens (3 shared papers)Edine Tiemersma (1 shared paper)D. Beaujean (1 shared paper)Albert J. de Neeling (1 shared paper)Jan Kluytmans (1 shared paper)N. van de Sande-Bruinsma (1 shared paper)Andreas Voß (1 shared paper)J Slusarczyk (1 shared paper)
- Journals
- Emerging infectious diseases (2 papers)Vaccine (2 papers)Journal of Clinical Microbiology (1 paper)Research Publications (Maastricht University) (1 paper)
- Partner nations
- NetherlandsFrancePoland
In The Last Decade
Inge van Loo
7 papers receiving 444 citations
Peers
Comparison fields: 5 of 56
- Clinical Biochemistry 185
- Infectious Diseases 338
- Microbiology 84
- Molecular Medicine 35
- Applied Microbiology and Biotechnology 14
Countries citing papers authored by Inge van Loo
This map shows the geographic impact of Inge van Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge van Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge van Loo more than expected).
Fields of papers citing papers by Inge van Loo
This network shows the impact of papers produced by Inge van Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge van Loo. The network helps show where Inge van Loo may publish in the future.
Co-authors
The 22 scholars most cited alongside Inge van Loo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 351 | |
| 2 | 2001 | 62 | |
| 3 | 2005 | 45 | |
| 4 | 2022 | 1 | |
| 5 | School Closure to Reduce Infl uenza Transmission | 2009 | 1 |
| 6 | 2009 | 1 | |
| 7 | Adenovirus Infection in Immunocompetent Children: Not Always as Innocent as Assumed | 2016 | 1 |
About Inge van Loo
Inge van Loo is a scholar working on Clinical Biochemistry, Infectious Diseases, Microbiology, Hepatology and Epidemiology, having authored 7 papers that have together received 462 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Bacterial biofilms and quorum sensing (2 papers), Indoor and Outdoor Localization Technologies (1 paper), Parvovirus B19 Infection Studies (1 paper), Infective Endocarditis Diagnosis and Management (1 paper), Clostridium difficile and Clostridium perfringens research (1 paper) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Clinical Biochemistry (185 citations), Infectious Diseases (338 citations), Microbiology (84 citations), Molecular Medicine (35 citations) and Applied Microbiology and Biotechnology (14 citations). Inge van Loo has collaborated with scholars based in Netherlands, France and Poland. Frequent co-authors include Xander W. Huijsdens, Edine Tiemersma, D. Beaujean, Albert J. de Neeling, Jan Kluytmans, N. van de Sande-Bruinsma, Andreas Voß, J Slusarczyk, Ewa Augustynowicz and Jan Kluytmans. Their work appears in journals such as Emerging infectious diseases, Vaccine, Journal of Clinical Microbiology and Research Publications (Maastricht University).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.